Eli Lilly’s Mounjaro Added to China’s State Insurance List for Diabetes Treatment
Wedoany.com Report-Dec.8, China's National Healthcare Security Administration announced on Sunday t...
Daehwa’s Oral Paclitaxel Liporaxel Added to China’s National Reimbursement List
Wedoany.com Report-Dec.8, Daehwa Pharmaceutical announced on Monday that its oral paclitaxel antican...
FDA Could Hike User Fees for Ex-US Drug Programmes
Wedoany.com Report-Dec.7, The U.S. Food and Drug Administration (FDA) is considering a proposal to r...
FDA Appoints Tracy Beth Høeg as Fifth CDER Head This Year
Wedoany.com Report-Dec.5, The U.S. Food and Drug Administration (FDA) has appointed Tracy Beth Høeg,...
Johnson & Johnson Wins EU Approval for New GMG Treatment
Wedoany.com Report-Dec.5, The European Commission has granted marketing authorisation for nipocalima...
Bayer Begins Phase 2 Trial of New Alport Syndrome Therapy
Wedoany.com Report-Dec.5, Evotec SE announced that its partner Bayer AG has started a Phase 2 clinic...
FDA Approves Eli Lilly’s Jaypirca in Relapsed or Refractory CLL/SLL
Wedoany.com Report-Dec.5, Eli Lilly and Company has obtained U.S. Food and Drug Administration (FDA)...
AGC Biologics to Expand Cell Line Development With ATUM Partnership
Wedoany.com Report-Dec.4, AGC Biologics has entered a strategic partnership with ATUM to incorporate...
Citizen Health and UCB Collaborate for Epilepsy Drug Development
Wedoany.com Report-Dec.4, Citizen Health has formed a multi-year strategic partnership with global b...
Novo Nordisk Gears up for December Ozempic Launch in India, Sources Say
Wedoany.com Report-Dec.4, Novo Nordisk, the Danish pharmaceutical company, plans to introduce its wi...